Clinical Observation of Shenmai Injection in Treatment of Primary Sjogren Syndrome / 中国药房

ABSTRACT

OBJECTIVE:To observe the clinical effect of Shenmai injection for primary sjogren syndrome.METHODS:61 patients were randomized to receive anethole trithione (control group,n=29) or anethole trithione and Shenmai injection (treatment group,n=32) respectively with 15 days as a course of treatment.RESULTS:The total effective rate was 68.96% for control group and 90.63% for treatment group.There were 3 cases of abdominal discomfort ordiarrhea in control group,and no serious ADR was detected in treatment group.Significant difference was noted between two groups (P